phase ii study of acalabrutinib plus rice in r/r dlbcl
Published 1 year ago • 111 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
3:58
phase ib/iia study of azd4573 acalabrutinib in r/r dlbcl
-
1:30
phase ib/iia study of azd4573 and acalabrutinib in patients with r/r dlbcl
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:08
overview of the phase i study with acalabrutinib (acp-196) in cll
-
2:40
epic update: observational study of first-line acalabrutinib treatment for cll
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
13:34
hematology basics: intro to the cbc the erythrocyte portion of the cbc
-
1:21:44
cell blocks and ihc in cytopathology
-
6:42
ib biology topic 11.1 (hl): antibody production & vaccination
-
3:05
car-t therapy in r/r dlbcl
-
1:04
phase i/ii study of bosutinib in newly diagnosed & resistant/intolerant pediatric patients with cml
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
0:42
targeted therapies for dlbcl treatment
-
1:38
using pet to predict failure to salvage therapy in patients with dlbcl
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
1:46
phase i study of costimulatory bispecific antibody ro7227166 combined with glofitamab in r/r b-nhl
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
1:18
results of a phase i study of sonrotoclax for the treatment of r/r waldenström’s macroglobulinemia
-
1:28
novel ultra-sensitive mrd profiling tool predicts outcomes in dlbcl after frontline treatment
-
1:39
phase i/ii trial of adct-602 in b-all
-
2:39
updates from the phase i/ii bruin study: pirtobrutinib in cll